All In MedTech

FDA Clearance Tracker · P140019-S004

i-FACTOR Peptide Enhanced Bone Graft

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jul 22, 2020 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jul 22, 2020

Approved

Time to decision

37 days

Received Jun 15, 2020. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P140019-S004
Device name
i-FACTOR Peptide Enhanced Bone Graft
Applicant location
Westminster, CO
Received
Jun 15, 2020
Decided
Jul 22, 2020
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - PAS
Original approval
P140019

Device type

Device class
Class III

Every decision under product code NOX

FDA's approval statement

As written in FDA's record.

Approval for updated labeling to include the results from the completed 72-month follow-up post-approval study.

Source documents

Other decisions for Cerapedics, LLC

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.